Trince
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $2.3M
Investors
- 2
About Trince
Founded in 2021 by Philip Mathuis, and Kevin Braeckmans, and based in Asse, Belgium, Trince a spin-off company from Ghent University operates as a biotechnology company that develops cancer solutions. The company's LumiPore transfection platform combines laser exposure with photothermal nanoparticles to convert light energy into heat to transiently permeabilize the cellular plasma membrane.
Who invested in Trince
2 investors across 1 round
See all investors in Trince
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 7, 2021
Amount
$2.3M
Investors
Questions about Trince
Who invested in Trince?
Trince has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trince raised?
Trince has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Trince last raise money?
Trince's most recent round on record is a Series A, in Dec 2021.
What does Trince do?
Founded in 2021 by Philip Mathuis, and Kevin Braeckmans, and based in Asse, Belgium, Trince a spin-off company from Ghent University operates as a biotechnology company that develops cancer solutions.
Where is Trince headquartered?
Trince is headquartered in Gent, Belgium.
Which VCs invest in companies like Trince?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Trince's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Trince? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.